Renalytix (NASDAQ:RNLX) reported its Q3 earnings results on Friday, June 9, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Renalytix missed estimated earnings by 27.27%, reporting an EPS of $-0.14 versus an estimate of $-0.11.
Revenue was down $88 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 7.56% increase in the share price the next day.
Here’s a look at Renalytix’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.14 | -0.13 | -0.19 | -0.19 |
| EPS Actual | -0.14 | -0.16 | -0.22 | -0.20 |
| Revenue Estimate | 1.28M | 1.10M | 800K | 700K |
| Revenue Actual | 1.19M | 969K | 831K | 812K |
To track all earnings releases for Renalytix visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
